“…One of the main reasons may be that the release of drugs encapsulated in the nanoparticles in the tumor was too slow or insufficient to play a considerable antitumor effect. This problem is not present in photothermal therapy because the photothermal agents encapsulated within the drug carrier have comparable or even better photothermal properties. , However, a specific carrier is still required to release autophagy inhibitors in time, right after the photothermal therapy. Thermosensitive liposomes are a vehicle that can carry drugs effectively and release them in a timely manner at high temperatures.…”